Loading…
Alkem Medtech, a subsidiary of Alkem Laboratories, has executed a binding offer to acquire up to a 55% stake in Swiss medical devices company Occlutech Holding AG for EUR 99.4 million (about ₹1,074 crore). The acquisition marks Alkem's entry into advanced cardiovascular devices.
Alkem MedTech Pvt Ltd, a subsidiary of Alkem Laboratories, has entered a design and technology transfer agreement with Exactech Inc to manufacture and market Exactech's knee and hip replacement implants in India.